Edward van Wezel, BioGeneration Ventures managing partner
July 13, 2023 07:00 AM EDT
Financing
Startups

Bio­Gen­er­a­tion Ven­tures clos­es $167M fund to hatch Eu­ro­pean star­tups with back­ing from Eli Lil­ly, No­vo, BMS

Amber Tong

Bio­Gen­er­a­tion Ven­tures, a Dutch ven­ture cap­i­tal firm ded­i­cat­ed to ear­ly-stage biotech star­tups, has closed its fifth fund at €150 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

A new dawn for psy­che­delics? Com­pass could be the first to find out

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

Strand Ther­a­peu­tics re­ports promis­ing start for mR­NA can­cer ther­a­py

No­var­tis won bid­ding war for kid­ney drug as Reg­u­lus' top three ex­ecs ex­pect to make over $100M com­bined

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times